ArticleInternational journal of molecular sciences2022

Treating iPSC-Derived β Cells with an Anti-CD30 Antibody-Drug Conjugate Eliminates the Risk of Teratoma Development upon Transplantation.

Silvia Pellegrini et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.